LanzaTech Global, Inc. Form 8-K Summary
Reporting date: February 8, 2023 closing date; the report was signed February 13, 2023. The filing documents the completion of AMCI Acquisition Corp. II’s business combination with Legacy LanzaTech. AMCI changed its name to LanzaTech Global, Inc., and Legacy LanzaTech became a wholly owned subsidiary. The combined company began trading on Nasdaq under LNZA and warrants under LNZAW.
Business Context and Reporting Period
LanzaTech develops gas-fermentation and carbon-refining technology that converts industrial emissions, municipal waste, biomass and other waste-carbon feedstocks into ethanol, sustainable aviation fuel, chemicals and protein products. The filing primarily provides Form 10 information following the de-SPAC transaction rather than reporting quarterly operating results.
- Three commercial-scale facilities in China had produced more than 50 million gallons of fuel-grade ethanol and mitigated more than 250,000 tons of CO2 as of the filing.
- Four commercial-scale facilities were under construction and eight additional commercial-scale facilities were in engineering; two further demonstration or smaller-scale facilities were in startup or commissioning.
- LanzaTech held approximately 25% of LanzaJet, which was developing a 10-million-gallon-per-year sustainable aviation fuel and renewable diesel facility in Georgia, expected to begin production in 2023.
- The company had more than 365 full-time equivalent employees as of December 31, 2022.
Key Financial and Capitalization Metrics
| Metric | Reported value or terms |
|---|---|
| Initial PIPE investment | 12.5 million shares at $10.00 per share; approximately $125 million of proceeds, including 3 million shares issued through conversion of the AMCI SAFE Note. |
| Additional private placements | 6 million shares at $10.00 per share; approximately $60 million of additional proceeds. |
| Total referenced private-placement proceeds | Approximately $185 million before transaction effects and expenses. |
| Shares outstanding after closing | 196,222,737 shares of common stock. |
| Trust account | $152,360,374 of investments and cash as of February 3, 2023, before applicable disbursements. |
| Brookfield SAFE | $50 million initial purchase amount; convertible into 5 million common shares at $10.00 per share, subject to the agreement. Any remaining amount is repayable on the fifth anniversary with high-single-digit compounded interest, subject to reductions tied to qualifying project funding. |
| LanzaJet notes | LanzaTech committed to purchase $5.5 million of subordinated secured notes, expected to be funded May 1, 2023. The notes carry 6.00% interest and mature December 31, 2043. |
| Dividends | No cash dividends have been paid. Management expects to retain earnings, if any, for operations and does not anticipate dividends in the foreseeable future. |
The filing text does not provide clear consolidated revenue, net income or loss, operating cash flow, free cash flow, cash balance after closing, gross margin, operating margin, total debt or liquidity runway for the combined company. It incorporates financial statements and unaudited pro forma information from the related proxy statement and Exhibit 99.2.
Material Changes Versus the Prior Comparable Period
- AMCI ceased to be a shell company and completed the acquisition of Legacy LanzaTech.
- Ownership, warrants, options, restricted stock awards and certain preferred-share dividend obligations were converted or settled into New LanzaTech securities using a 4.374677 exchange ratio.
- Legacy LanzaTech options covering 3,271,104 underlying shares were converted into options covering approximately 14,310,025 New LanzaTech shares, with exercise prices adjusted to approximately $0.16 to $9.97.
- Seven directors were appointed, Jennifer Holmgren became board chair and chief executive officer, and Geoff Trukenbrod became chief financial officer.
- The company adopted a 2023 long-term incentive plan, annual bonus plan, executive severance plan and new code of conduct and ethics.
- Deloitte & Touche was appointed as the combined company’s independent registered public accounting firm. Marcum was dismissed after completing its audit of AMCI’s 2022 financial statements. Marcum had previously reported material weaknesses related to complex financial instruments and certain advisory and placement-agent fees.
Guidance, Outlook, Risks and Unusual Items
No formal consolidated revenue or earnings guidance is provided in the filing. Management describes a growth strategy based on licensing, royalties, engineering and services, equipment and supply sales, and selective co-development investments. The company expects additional commercial facilities and sustainable aviation fuel projects to support future growth, but timing and economics remain dependent on financing, construction, permitting, technology performance, feedstock availability, customer commitments and government incentives.
- Forward purchase arrangement: A seller may purchase up to 10 million AMCI shares, with the transaction funded from the trust account. The agreement includes a prepayment shortfall of up to $2.5 million, potential increases to that shortfall, reset-price provisions, possible warrants, indemnification obligations and a maturity payment that may be made in cash or shares.
- Potential dilution and repayment obligations: The Brookfield SAFE, converted preferred interests, warrants, options, equity compensation and forward purchase agreement may result in significant future dilution or cash obligations.
- Project execution: Many facilities remain under construction, in engineering, commissioning or demonstration stages and may not reach commercial operation on expected schedules or economics.
- Regulatory exposure: LanzaTech-derived ethanol from industrial emissions did not qualify for Renewable Identification Numbers under the U.S. Renewable Fuel Standard as described in the filing. Approvals for fuels, chemicals and genetically modified microorganisms vary by jurisdiction.
- Financing and capital intensity: The company states that substantial additional financing may be required to fund operations and commercialize its technologies. Brookfield is not obligated to invest in projects presented under the framework agreement.
- Market and technology risks: The business is exposed to competition, volatile energy and commodity markets, variable feedstock composition, technology scale-up risk, intellectual-property challenges, litigation, climate-policy changes and the availability of government grants or incentives.
- Unusual accounting and control item: AMCI’s prior auditor identified material weaknesses, and the filing references substantial doubt about AMCI’s ability to continue as a going concern as of December 31, 2021.
Most Important Facts for an Investor to Verify
- Review Exhibit 99.2 and the incorporated financial statements for actual revenue, losses, cash burn, debt, liquidity and pro forma capitalization.
- Reconcile the $185 million of referenced PIPE proceeds with trust-account cash, redemptions, transaction expenses and cash available to LanzaTech after closing.
- Quantify fully diluted shares, including the Brookfield SAFE, public and private warrants, converted options, restricted awards and forward-purchase-related securities.
- Review the Forward Purchase Agreement for potential share issuance, maturity payments, reset-price mechanics, shortfall obligations and restrictions on future financings.
- Assess the funding and completion status of the commercial facilities and LanzaJet projects, including expected capital requirements and customer or government support.
- Confirm the accounting treatment and remaining obligations associated with the Brookfield SAFE, LanzaJet notes and other project-level commitments.
- Evaluate the auditor transition and remediation of the material weaknesses disclosed by Marcum.